How Can Metabolomics Detect Drug Toxicity Early? How much does our environment influence our health—and what could that mean for precision medicine? How can researchers identify drug toxicity before it becomes a clinical problem? Metabolomics may offer a way to detect potential safety risks earlier in drug development. In this episode of ChatGJP, Panome Bio […]
Can Metabolomics Explain Differences in Drug Response? How much does our environment influence our health—and what could that mean for precision medicine? Why does a drug work well for some patients but have little effect on others? Differences in underlying disease biology may hold important clues. In this episode of ChatGJP, Panome Bio CSO Gary […]
Discover how targeted metabolomics enables more accurate evaluation of PRMT5 therapies, supports biomarker discovery, and drives translational breakthroughs in oncology in this webinar.
What Industries Benefit from Exposomics Analysis? How much does our environment influence our health—and what could that mean for precision medicine? Which industries can benefit from exposomics analysis? The answer extends beyond healthcare. In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how exposomics can provide valuable insights for drug development, precision […]
Is Exposomics the Missing Link in Precision Medicine? How much does our environment influence our health—and what could that mean for precision medicine? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explores how exposomics can help researchers understand the relationship between environmental chemical exposures and human health. From pollutants and pesticides to […]
How Are Environmental Chemicals Linked to Parkinson’s Disease? How are environmental chemical exposures linked to Parkinson’s disease, and what could these connections mean for drug development? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explores emerging research on environmental chemicals and their potential role in neurodegenerative disease. The conversation also dives into […]
Why Has Genomics Not Solved Most Chronic Diseases? Why hasn’t genomics solved most chronic diseases? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains why genomics has provided valuable insights into health and disease, but cannot capture every factor that influences an individual’s health. While genomics has been applied at enormous population […]
How Is Multi-Omics Changing Chronic Disease Diagnosis? How is multi-omics changing the way researchers define and diagnose chronic disease? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how combining molecular data can provide greater resolution into the biological differences between patients and disease states. Chronic diseases can exist along a spectrum, […]
What Is the Biggest Challenge in Integrating Multi-Omics Data? How can researchers make complex multi-omics datasets work together? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains the challenges of integrating genomics, proteomics, metabolomics, and exposomics data and why synchronization is key to extracting meaningful biological insights. Rather than analyzing each omics […]
How Can Proteomics Track Therapeutic Response in Real Time? How can proteomics help researchers track how well a therapy is working in real time? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explores how protein biomarkers can provide a dynamic view of disease activity and therapeutic response. Using Alzheimer’s disease and the […]